ArticleInternational journal of clinical oncology2021

Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater.

Takayuki Jodai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.